Unknown

Dataset Information

Left atrial appendage thrombus formation in a patient with atrial fibrillation on dabigatran therapy associated with CES1 and ABCB1 genetic polymorphisms: A case report.


ABSTRACT:

Rationale

Dabigatran is a direct thrombin inhibitor that is widely used to prevent the formation of thrombus formation. Amiodarone can increase the plasma concentration of dabigatran. CES1 (carboxylesterase 1) and ABCB1 (ATP-binding cassette subfamily B member 1) genetic polymorphisms associate with the pharmacokinetics of dabigatran.

Patient concerns

A 62-year-old woman was admitted to the hospital due to chest tightness, fatigue, and discomfort despite long-term anticoagulation with dabigatran 110 mg twice daily for 6 months, with concomitant use of amiodarone.

Diagnoses

Left atrial appendage thrombus formation with a history of atrial fibrillation.

Interventions

The clinician changed dabigatran to warfarin. To explore the causes of insufficient anticoagulati

SUBMITTER: Wu T 

PROVIDER: S-EPMC7478673 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature